Mailbag: Spooked About Allergan ($AGN)

Erik Kobayashi-Solomon

January 26, 2017

Pharma companies have been in the news a lot lately, and while people say there is no such thing as bad press, it seems like some firms like specialty drug maker Allergan (AGN), may disagree. Three different IOI members have asked me about Allergan recently, and the interest has been so intense that I have started …

Let's Chat

Use the form below to ask us any questions.


Current students can use this form to access our courses dashboard.

Not a student? Start a Free Trial!

Sign Up to View

Please enter your email to access to gain access to "Mailbag: Spooked About Allergan ($AGN)"

Contact Information

Know someone else who could benefit from Framework Investing industry leading investment research and investor training?